𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Should Eligible Patients with T-Cell Lymphoma Receive High-Dose Therapy and Autologous Stem Cell Transplant in the Upfront Setting?

✍ Scribed by Carla Casulo; Steven Horwitz


Book ID
107546773
Publisher
Current Science Inc.
Year
2010
Tongue
English
Weight
166 KB
Volume
12
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Chemotherapy with rituximab followed by
✍ Catherine Thieblemont; Daciana Antal; Laurence Lacotte-Thierry; Vincent Delwail; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 122 KB

## Abstract ## BACKGROUND The authors evaluated the efficacy of chemotherapy combined with rituximab followed by high‐dose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL). ## METHODS This was a retrospective analysis of 34 patients who were tre